BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34532768)

  • 1. 3-T MRI and clinical validation of ultrasound-guided transperineal laser ablation of benign prostatic hyperplasia.
    Manenti G; Perretta T; Calcagni A; Ferrari D; Ryan CP; Fraioli F; Meucci R; Malizia A; Iacovelli V; Agrò EF; Floris R
    Eur Radiol Exp; 2021 Sep; 5(1):41. PubMed ID: 34532768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-guided transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a new minimally invasive interventional therapy.
    Cai HJ; Fang JH; Kong FL; Xu CK; Chen CH; Wang W; Huang B
    Acta Radiol; 2022 Apr; 63(4):553-558. PubMed ID: 33779301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-guided SoracteLite™ transperineal laser ablation (TPLA) of the prostate for the treatment of symptomatic benign prostatic hyperplasia (BPH): a prospective single-center experience.
    Laganà A; Di Lascio G; Di Blasi A; Licari LC; Tufano A; Flammia RS; De Carolis A
    World J Urol; 2023 Apr; 41(4):1157-1162. PubMed ID: 36853444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction.
    de Rienzo G; Lorusso A; Minafra P; Zingarelli M; Papapicco G; Lucarelli G; Battaglia M; Ditonno P
    Eur Urol; 2021 Jul; 80(1):95-103. PubMed ID: 32868137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic hyperplasia: 12-month clinical outcomes of a phase I study.
    Viitala A; Anttinen M; Wright C; Virtanen I; Mäkelä P; Hovinen T; Sainio T; Saunavaara J; Taimen P; Blanco Sequeiros R; Boström PJ
    BJU Int; 2022 Feb; 129(2):208-216. PubMed ID: 34161649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relief of Lower Urinary Tract Symptoms After MRI-Guided Transurethral Ultrasound Ablation for Localized Prostate Cancer: Subgroup Analyses in Patients with Concurrent Cancer and Benign Prostatic Hyperplasia.
    Elterman D; Li W; Hatiboglu G; Relle J; Zorn KC; Bhojani N; Chin J
    J Endourol; 2021 Apr; 35(4):497-505. PubMed ID: 32935575
    [No Abstract]   [Full Text] [Related]  

  • 7. Feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experience.
    Frego N; Saita A; Casale P; Diana P; Contieri R; Avolio PP; Lazzeri M; Hurle R; Buffi NM; Guazzoni GF; Lughezzani G
    World J Urol; 2021 Oct; 39(10):3867-3873. PubMed ID: 33811512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transperineal laser ablation as treatment for benign prostatic obstruction: Safety, feasibility and functional outcomes-A pilot study.
    van Kollenburg R; van Riel L; Bloemen P; de Reijke T; Beerlage H; de Bruin D; Oddens J
    BJUI Compass; 2024 Jan; 5(1):52-59. PubMed ID: 38179027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transperineal Laser Ablation Treatment for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction: Protocol for a Prospective In Vivo Pilot Study.
    van Kollenburg RAA; van Riel LAMJG; Bloemen PR; Oddens JR; de Reijke TM; Beerlage HP; de Bruin DM
    JMIR Res Protoc; 2020 Jan; 9(1):e15687. PubMed ID: 31961326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New and Emerging Technologies in Treatment of Lower Urinary Tract Symptoms From Benign Prostatic Hyperplasia.
    Gupta NK; Gange SN; McVary KT
    Sex Med Rev; 2019 Jul; 7(3):491-498. PubMed ID: 29606553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Design and Rationale of a Multicentre Randomised Controlled Trial Comparing Transperineal Percutaneous Laser Ablation With Transurethral Resection of the Prostate for Treating Benign Prostatic Hyperplasia.
    Zhang W; Zhang W; Guo Q; Chen L; Meng Z; Xu Y; Cao N; Hu B; Qian B
    Front Surg; 2021; 8():755957. PubMed ID: 34733883
    [No Abstract]   [Full Text] [Related]  

  • 14. Operative profile, safety and functional outcomes after GreenLight laser prostate surgery: results from a 12 months follow-up multicenter Italian cohort analyses.
    Reale G; Marchioni M; Altieri V; Greco F; De Nunzio C; Destefanis P; Ricciardulli S; Bergamaschi F; Fasolis G; Varvello F; Voce S; Palmieri F; Divan C; Malossini G; Oriti R; Tuccio A; Ruggera L; Tubaro A; Delicato G; Laganà A; Dadone C; De Rienzo G; Ditonno A; Frattini A; Pucci L; Carrino M; Montefiore F; Germani S; Miano R; Schips L; Rabito S; Ferrari G; Cindolo L
    Minerva Urol Nefrol; 2020 Oct; 72(5):622-628. PubMed ID: 32284526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation.
    Nguyen DD; Li T; Ferreira R; Baker Berjaoui M; Nguyen AV; Chughtai B; Zorn KC; Bhojani N; Elterman D
    Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):22-28. PubMed ID: 37081044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study.
    Patelli G; Ranieri A; Paganelli A; Mauri G; Pacella CM
    Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1440-1446. PubMed ID: 28474112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transperineal Laser Ablation of the Prostate (TPLA) for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction.
    Sessa F; Polverino P; Siena G; Bisegna C; Lo Re M; Spatafora P; Pecoraro A; Rivetti A; Moscardi L; Saladino M; Cocci A; Gacci M; Li Marzi V; Carini M; Minervini A; Campi R; Serni S
    J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrasound indicators of the prostate, urinary bladder and uroflowmetry parameters in the diagnosis of infravesical obstruction in men with benign prostatic hyperplasia].
    Krivoborodov GG; Efremov NS; Bolotov AD
    Urologiia; 2017 Oct; (5):9-14. PubMed ID: 29135135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three years outcomes of transperineal laser ablation of the prostate.
    Minafra P; DE Rienzo G; Gerbasi S; Cindolo L; Battaglia M; Ditonno P
    Minerva Urol Nephrol; 2023 Aug; 75(4):471-478. PubMed ID: 37314812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Sexual Function Better Preserved After Water Vapor Thermal Therapy or Medical Therapy for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia?
    McVary KT; Rogers T; Mahon J; Gupta NK
    J Sex Med; 2018 Dec; 15(12):1728-1738. PubMed ID: 30446471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.